CNR1 and schizophrenia: Post-mortem studies carried out on the brains of patients with schizophrenia have demonstrated alterations to the CB1R, such as reduced levels of its mRNA and protein expression in the dorsolateral prefrontal cortex [94], or increased CB1R binding in the corticolimbic areas implicated in this disorder [95, 96, 97].